Latest Post

The Top Ingredients to Look For in Menopausal Skin-Care Probiotics: Solving Poor Digestive Health How to Do Double Leg Lift in Pilates? Tips, Technique, Correct Form, Benefits and Common Mistakes Top 5 Emerging Skincare Markets in 2022: Brazil, China, India, Mexico and South Africa – Market Summary, Competitive Analysis and Forecast to 2025 – ResearchAndMarkets.com Kelvin Harrison Jr. Is Growing with the Flow

Source / Disclosures

Source:

Blumenthal PD, et al. Abstract 91. Presented at ACOG Annual Clinical & Scientific Meeting; May 6-8, 2022; San Diego.

Disclosures:
Blumenthal reports no relevant financial disclosures. Please see the study for all other authors’ relevant financial disclosures.


We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

SAN DIEGO – Passively self-collected menstrual blood for the detection of HPV showed results that were highly concordant with clinician-collected sampling and had greater acceptance among patients, researchers reported here.

In this case, passive menstrual blood collection was done using Q-Pads (Qvin), which are menstrual pads with a removable collection strip that works as a dried blood spot test. According to the Qvin website, the Q-pad also collects blood to show information regarding hormones, vitamins and the risk for diabetes.

Using a modified menstrual pad to collect blood samples for HPV testing had similar efficacy in detecting positive cases compared with clinician-collected samples. Source: Adobe Stock

In terms of this study focusing on screening for high-risk HPV (HR-HPV), we felt that if we are going to eliminate cervical cancer globally, then we need better access to screening modalities that are convenient, comfortable, cost-effective and require relatively little initiative on the part of the patient, ” Paul D. Blumenthal, MD, professor emeritus of OB / GYN and director of the Stanford Program for International Reproductive Education and Services at Stanford University in California, told Healio. “Passively collecting menstrual blood via the Q-Pad could meet a lot of these criteria, and in this preliminary report, it appears to be the case.

“We also feel that if menstrual blood was shown to be a useful clinical tool and not merely a waste product, it could help reduce the burden of menstrual stigma – which is a challenge for women globally – and help them recognize that their monthly curse ‘is actually a valuable health resource, ”he added.

Among 153 participants who presented for cervical cancer screening or who had a history of HPV, Blumenthal and colleagues included 107 who had a clinician-collected cervical specimen and who provided a Q-Pad sample after use during their next menses.

We were pleasantly surprised that the correlation between clinician-collected swabs and the Q-Pad finding among those who were HR-HPV positive was as high as it was (94%), especially since this was the first time that dried blood spot derived from menstrual blood had been used for this purpose, ”Blumenthal said.

Of note, 12% of patients who tested positive for HR-HPV with Q-Pad samples had negative clinician-collected samples.

Overall, 94% of patients recommended providing a Q-Pad sample over clinician-collected samples. Additionally, 30% of patients refused to provide a self-collected swab for testing, citing discomfort.

“Screening for HR-HPV using menstrual blood – and specifically the Q-Pad as a collection vehicle – is both feasible from a technical and accuracy perspective, and also highly acceptable to women,” Blumenthal said. “It shows promise as a screening approach that might be scalable.”

References:

  • Blumenthal PD, et al. Abstract 91. Presented at: ACOG Annual Clinical & Scientific Meeting; May 6-8, 2022; San Diego.
  • Qvin. https://qvin.com/en/. Accessed May 7, 2022.

Leave a Reply

Your email address will not be published. Required fields are marked *